154 related articles for article (PubMed ID: 9356229)
1. Role of platelet-activating factor in hepatocellular Ca2+ alterations during hemorrhagic shock.
Silomon M; Pizanis A; Larsen R; Rose S
J Surg Res; 1997 Oct; 72(2):101-6. PubMed ID: 9356229
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline prevention of altered hepatocyte calcium regulation during hemorrhagic shock/resuscitation.
Silomon M; Pizanis A; Larsen R; Rose S
Crit Care Med; 1998 Mar; 26(3):494-500. PubMed ID: 9504578
[TBL] [Abstract][Full Text] [Related]
3. Oxyradical-mediated hepatocellular Ca2+ alterations during hemorrhagic shock and resuscitation.
Silomon M; Pizanis A; Rose S
Shock; 1999 Mar; 11(3):193-8. PubMed ID: 10188772
[TBL] [Abstract][Full Text] [Related]
4. Altered hepatocellular Ca2+ regulation during hemorrhagic shock and resuscitation.
Rose S; Pizanis A; Silomon M
Hepatology; 1997 Feb; 25(2):379-84. PubMed ID: 9021950
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody to tumor necrosis factor-alpha modulates hepatocellular Ca2+ homeostasis during hemorrhagic shock in the rat.
Pizanis A; Mutschler W; Rose S
J Mol Med (Berl); 1999 Jan; 77(1):8-13. PubMed ID: 9930921
[TBL] [Abstract][Full Text] [Related]
6. Effect of sodium bicarbonate infusion on hepatocyte Ca2+ overload during resuscitation from hemorrhagic shock.
Silomon M; Rose S
Resuscitation; 1998 Apr; 37(1):27-32. PubMed ID: 9667335
[TBL] [Abstract][Full Text] [Related]
7. Oxygen-derived free radicals in kidney in experimental hemorrhagic shock treated by PAF-receptor antagonist BN 52021.
Kirejczyk JK; Debek W; Dziecioł J; Chyczewski L; Makarewicz M; Nikliński J
Rocz Akad Med Bialymst; 1995; 40(1):77-87. PubMed ID: 8528997
[TBL] [Abstract][Full Text] [Related]
8. Starch-deferoxamine conjugate inhibits hepatocyte Ca2+ uptake during hemorrhagic shock and resuscitation.
Rose S; Pizanis A; Silomon M
J Trauma; 2000 Aug; 49(2):291-6; discussion 296-7. PubMed ID: 10963542
[TBL] [Abstract][Full Text] [Related]
9. Role of platelet-activating factor in leukocyte-independent plasma extravasation and mast cell activation during endotoxemia.
Walther A; Yilmaz N; Schmidt W; Bach A; Gebhard MM; Martin E; Schmidt H
J Surg Res; 2000 Oct; 93(2):265-71. PubMed ID: 11027469
[TBL] [Abstract][Full Text] [Related]
10. Ginkgolide BN 52021 protects against hemorrhagic shock-induced renal injury in rats.
Kirejczyk JK; Chyczewski L; Debek W
Rocz Akad Med Bialymst; 1995; 40(1):65-76. PubMed ID: 8528996
[TBL] [Abstract][Full Text] [Related]
11. Luminol-chemiluminescence in free peritoneal cells in hemorrhagic shock in rats treated with PAF-receptor-antagonist BN 52021.
Debek W; Gruca P; Chyczewski L; Gruca A
Rocz Akad Med Bialymst; 1995; 40(1):129-37. PubMed ID: 8528982
[TBL] [Abstract][Full Text] [Related]
12. [Involvement of platelet activating factors in pathologic leukocyte-endothelium interactions in the liver after hemorrhagic shock].
Marzi I; Bauer M; Reisdorf E; Walcher F
Zentralbl Chir; 1994; 119(11):814-21. PubMed ID: 7846961
[TBL] [Abstract][Full Text] [Related]
13. Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock.
De Kimpe SJ; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Dec; 116(8):3191-8. PubMed ID: 8719795
[TBL] [Abstract][Full Text] [Related]
14. [Influence of platelet activating factor and its antagonist on portal hypertension associated with liver cirrhosis: an experiment with rats].
Wang CP; Han J; Ma XM; Dong K; Xiang Y; Su SH; Feng YY; Yang YP
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3337-41. PubMed ID: 16409839
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor receptor-antagonist (BN 52021) stabilizes the oxidative-antioxidative balance and attenuates the morphological changes in the gastrointestinal tract in experimental hemorrhagic shock.
Debek W; Chyczewski L; Makarewicz M
Exp Toxicol Pathol; 1998 Mar; 50(1):19-25. PubMed ID: 9570497
[TBL] [Abstract][Full Text] [Related]
16. Effect of platelet-activating factor (PAF) receptor antagonist (BN52021) on acetaminophen-induced acute liver injury and regeneration in rats.
Grypioti AD; Theocharis SE; Demopoulos CA; Papadopoulou-Daifoti Z; Basayiannis AC; Mykoniatis MG
Liver Int; 2006 Feb; 26(1):97-105. PubMed ID: 16420515
[TBL] [Abstract][Full Text] [Related]
17. Effect of increased hepatic platelet activating factor and its receptor portal hypertension in CCl4-induced liver cirrhosis.
Yang YP; Ma XM; Wang CP; Han J; Lu YY; Xiang Y; Su SH; Feng YY
World J Gastroenterol; 2006 Feb; 12(5):709-15. PubMed ID: 16521183
[TBL] [Abstract][Full Text] [Related]
18. Interplay among platelet-activating factor, oxidative stress, and group I metabotropic glutamate receptors modulates neuronal survival.
Zhu P; DeCoster MA; Bazan NG
J Neurosci Res; 2004 Aug; 77(4):525-31. PubMed ID: 15264222
[TBL] [Abstract][Full Text] [Related]
19. Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis.
Yang Y; Nemoto EM; Harvey SA; Subbotin VM; Gandhi CR
Gut; 2004 Jun; 53(6):877-83. PubMed ID: 15138217
[TBL] [Abstract][Full Text] [Related]
20. BN52021 stabilizes the oxidant-antioxidant equilibrium in peritoneal lavage fluid in experimental hemorrhagic shock.
Debek W; Chyczewski L; Farbiszewski R
Folia Histochem Cytobiol; 1999; 37(4):249-54. PubMed ID: 10598326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
